BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR)
Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Oct 7, 2022
Trial Information
Current as of May 19, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR) is a clinical trial designed to study how different types of nutritional supplements can affect the health of pregnant women and their babies. The main goal is to see if a special supplement that includes energy and protein (called BEP) can help improve birth weight and reduce issues like low birth weight, small-for-gestational age babies, and preterm births, compared to another supplement that contains multiple vitamins and minerals (MMS). The researchers will recruit pregnant women in the early stages of their pregnancy and randomly assign them to different groups: some will receive the BEP supplement daily, while others will get the MMS or a combination based on their weight and health.
To participate in this study, women need to be married, between the ages of 15 and 35, and living in the study area. They also need to be pregnant and agree to take part in the research. Women who are currently pregnant beyond 28 weeks, recently gave birth, or are widowed or divorced will not be included. Participants can expect to receive nutritional support throughout their pregnancy, and the researchers will closely monitor the health of both the mothers and their babies. This study aims to provide valuable information on how nutrition can support healthier pregnancies and better birth outcomes.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Married women of reproductive age (15-35 y)
- • living in the selected study area who are pregnant and consent to participate in the study.
- Exclusion Criteria:
- • Currently pregnant or lactating women (through 12 months postpartum),
- • Married women who are sterilized or widowed/divorced will not be included in the pregnancy surveillance being used to identify newly pregnant women.
- • Women with gestational age of \>=28 weeks of gestation using reported last menstrual period.
About Johns Hopkins Bloomberg School Of Public Health
The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rangpur, , Bangladesh
Patients applied
Trial Officials
Parul Christian, DrPH
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials